Detection_NN of_IN Simian_NP Immunodeficiency_NN Virus_NP in_IN Diverse_NP Species_NP and_CC of_IN Human_NP Immunodeficiency_NN Virus_NP Type_NP 2_CD by_IN Using_VBG Consensus_NP Primers_NP within_IN the_DT pol_NN Region_NP Human_NP immunodeficiency_NN virus_NN type_NN 2_CD (_( HIV-2_NP )_) is_VBZ the_DT result_NN of_IN cross-species_NNS transmission_NN of_IN simian_JJ immunodeficiency_NN virus_NN (_( SIV_NP )_) from_IN sooty_JJ mangabey_NN monkeys_NNS to_TO humans_NNS ._SENT Primer_JJR pairs_NNS (_( intHIV-2/SIV_NN )_) based_VBN on_IN a_DT region_NN of_IN integrase_NN that_WDT has_VBZ considerable_JJ homology_NN across_IN HIV-2_NP and_CC SIV_NP lineages_NNS were_VBD designed_VBN to_TO develop_VB a_DT broadly_RB cross-reactive_JJ molecular_JJ assay_NN to_TO detect_VB lentivirus_NN infection_NN in_IN primates_NNS ._SENT The_DT intHIV-2/SIV_NP primers_NNS detect_VBP HIV-2_JJ and_CC simian_JJ viruses_NNS SIVcpz_NP ,_, SIVsmm_NP ,_, SIVsyk_NP ,_, SIVagm_NP ,_, and_CC SIVmnd_NP ._SENT The_DT primers_NNS are_VBP also_RB capable_JJ of_IN amplifying_VBG some_DT HIV-1_JJ strains_NNS ._SENT Additionally_RB ,_, sequences_NNS from_IN the_DT integrase_NN amplicons_NNS were_VBD of_IN sufficient_JJ genetic_JJ diversity_NN to_TO permit_VB not_RB only_RB phylogenetic_JJ clustering_VBG of_IN all_DT simian_JJ viruses_NNS to_TO their_PP$ respective_JJ lineages_NNS but_CC also_RB HIV_NP type_NN and_CC group_NN classification_NN ._SENT Thus_RB ,_, the_DT primers_NNS described_VBD here_RB provide_VB a_DT method_NN to_TO detect_VB primate_NN lentiviruses_NNS from_IN diverse_JJ species_NNS of_IN nonhuman_NN primates_NNS ,_, as_RB well_RB as_IN from_IN persons_NNS infected_VBN with_IN HIV-1_NP and_CC HIV-2_NP ._SENT Zoonotic_JJ transmission_NN is_VBZ an_DT important_JJ factor_NN in_IN the_DT emergence_NN of_IN retroviruses_NNS and_CC other_JJ infectious_JJ agents_NNS in_IN humans_NNS ._SENT At_IN least_JJS 20_CD different_JJ nonhuman_NN primate_NN species_NNS in_IN Africa_NP have_VBP been_VBN shown_VBN to_TO harbor_VB simian_JJ immunodeficiency_NN viruses_NNS (_( SIVs_NP )_) ._SENT Thus_RB ,_, African_JJ primates_NNS represent_VBP an_DT extremely_RB large_JJ reservoir_NN of_IN lentiviruses_NNS that_WDT can_MD potentially_RB infect_VB other_JJ species_NNS including_VBG humans_NNS ._SENT Indeed_RB ,_, the_DT extensive_JJ phylogenetic_JJ relatedness_NN among_IN many_JJ strains_NNS of_IN human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) and_CC HIV-2_NP and_CC primate_NN lentiviruses_NNS has_VBZ elucidated_VBN the_DT simian_JJ origin_NN of_IN AIDS_NP ._SENT These_DT studies_NNS have_VBP further_RBR established_VBN that_IN HIV-1_JJ infection_NN ,_, the_DT main_JJ cause_NN of_IN the_DT worldwide_JJ AIDS_NP pandemic_NN ,_, was_VBD the_DT result_NN of_IN cross-species_NNS transmission_NN of_IN SIV_NP from_IN chimpanzees_NNS (_( Pan_NP troglodytes_NNS troglodytes_NNS )_) to_TO humans_NNS (_( ,_, ,_, -_: )_) ._SENT Likewise_RB ,_, the_DT HIV-2_NP epidemic_NN seems_VBZ to_TO have_VB emerged_VBN via_IN cross-species_NNS transmission_NN of_IN SIV_NP from_IN sooty_JJ mangabey_NN monkeys_NNS (_( Cercocebus_NP sp_NP ._SENT )_) ._SENT Current_JJ evidence_NN indicates_VBZ that_IN the_DT SIV_NP counterparts_NNS of_IN HIV-1_NP and_CC HIV-2_NP were_VBD introduced_VBN into_IN the_DT human_JJ population_NN multiple_JJ times_NNS (_( at_IN least_JJS seven_CD transmission_NN events_NNS have_VBP been_VBN suggested_VBN )_) ._SENT Yet_RB ,_, the_DT HIV-1_NP group_NN M_NN viruses_NNS appear_VBP to_TO have_VB arisen_VBN from_IN just_RB one_CD such_JJ zoonotic_JJ transmission_NN ._SENT Thus_RB ,_, while_IN cross-species_NNS transmission_NN of_IN primate_NN retroviruses_NNS to_TO humans_NNS occurs_VBZ relatively_RB frequently_RB ,_, the_DT subsequent_JJ spread_NN of_IN the_DT retroviruses_NNS in_IN the_DT human_JJ population_NN is_VBZ rare_JJ ._SENT Nevertheless_RB ,_, this_DT scenario_NN represents_VBZ a_DT unique_JJ opportunity_NN to_TO study_VB both_CC the_DT emergence_NN of_IN new_JJ human_JJ retroviruses_NNS and_CC the_DT genetic_JJ diversities_NNS of_IN these_DT human_JJ and_CC simian_JJ viruses_NNS ._SENT The_DT primate_NN lentiviruses_NNS for_IN which_WDT full-length_JJ genomic_JJ sequences_NNS are_VBP available_JJ fall_NN into_IN five_CD major_JJ equidistant_JJ phylogenetic_JJ lineages_NNS :_: (_( i_NP )_) SIVcpz_NP from_IN chimpanzees_NNS ,_, together_RB with_IN HIV-1_JJ ;_: (_( ii_NP )_) SIVsmm_NP from_IN sooty_JJ mangabey_NN monkeys_NNS together_RB with_IN HIV-2_JJ ;_: (_( iii_NP )_) SIVagm_NP from_IN four_CD species_NNS of_IN African_JJ green_JJ monkeys_NNS ;_: (_( iv_NP )_) SIVsyk_NP from_IN Sykes_NP monkeys_NNS ;_: and_CC (_( v_NN )_) SIVmnd_NP and_CC SIVlhoest_NP from_IN mandrills_NNS and_CC l'Hoest_NN monkeys_NNS ,_, respectively_RB (_( ,_, ,_, ,_, ,_, -_: ,_, )_) ._SENT Recently_RB ,_, an_DT additional_JJ SIV_NP (_( SIVcol_NP )_) from_IN Guereza_NP colobus_NN monkeys_NNS (_( Colobus_NP guereza_NP )_) ,_, representing_VBG a_DT sixth_JJ lineage_NN of_IN primate_NN lentivirus_NN ,_, has_VBZ been_VBN identified_VBN ._SENT Therefore_RB ,_, studies_NNS are_VBP needed_VBN to_TO determine_VB whether_IN transmission_NN of_IN simian_JJ lentiviruses_NNS other_JJ than_IN SIVcpz_NP and_CC SIVsmm_NP to_TO humans_NNS is_VBZ occurring_VBG ,_, particularly_RB in_IN regions_NNS where_WRB SIV_NP infection_NN in_IN nonhuman_NN primates_NNS is_VBZ highly_RB prevalent_JJ ._SENT These_DT studies_NNS require_VBP the_DT development_NN of_IN molecular_JJ detection_NN assays_NNS that_WDT can_MD detect_VB a_DT wide_JJ range_NN of_IN lentivirus_NN infections_NNS in_IN both_DT nonhuman_NN primates_NNS and_CC humans_NNS ._SENT We_PP have_VBP recently_RB described_VBN serologic_JJ and_CC molecular_JJ diagnostic_JJ assays_NNS that_WDT permit_VBP detection_NN of_IN highly_RB divergent_JJ HIV-1_JJ strains_NNS and_CC their_PP$ simian_JJ counterpart_NN ,_, SIVcpz_NP ._SENT Here_RB we_PP report_VBP a_DT sensitive_JJ and_CC broadly_RB reactive_JJ PCR-based_JJ molecular_JJ screening_NN tool_NN for_IN detecting_VBG HIV-2_NP and_CC SIVs_NP from_IN diverse_JJ species_NNS of_IN primates_NNS ._SENT More_RBR importantly_RB ,_, sequences_NNS generated_VBD from_IN these_DT PCR_NP products_NNS can_MD be_VB reliably_RB used_VBN for_IN phylogenetic_JJ classification_NN within_IN the_DT HIV-2_NP and_CC SIV_NP lineages_NNS ,_, thus_RB permitting_VBG identification_NN of_IN the_DT zoonotic_JJ source_NN of_IN infection_NN ._SENT Primer_JJR design_NN ._SENT |_SYM Primers_NP were_VBD designed_VBN based_VBN on_IN the_DT consensus_NN sequences_NNS in_IN the_DT pol_NN region_NN of_IN HIV-2_NP and_CC SIV_NP and_CC are_VBP designated_VBN intHIV-2/SIV_NP primers_NNS ._SENT For_IN reverse_JJ transcription_NN (_( RT_NP )_) and_CC primary_JJ PCR_NP ,_, the_DT primers_NNS were_VBD INT-F1_JJ (_( forward_VB ;_: 5'-ATAGAACCAGCACAAGAAGAACAT_NN ;_: nucleotides_NNS 2241_CD to_TO 2264_CD based_VBN on_IN HIV-2_NP ROD_NP )_) and_CC INT-R1_JJ (_( reverse_VB ;_: 5'-ACTGCTCCTTCACCTTTCCA_NP ;_: nucleotides_NNS 2956_CD to_TO 2975_CD )_) ._SENT The_DT primers_NNS for_IN the_DT nested_VBN PCR_NP were_VBD INT-F2_JJ (_( forward_VB ;_: 5'-AATGTCAACAGAAAGGAGAAGCTATACAT_NN ;_: nucleotides_NNS 2354_CD to_TO 2383_CD )_) and_CC INT-R2_NP (_( reverse_VB ;_: 5'-CCCCTATTCCTCCCTTCTTTTAAAAT_NN ;_: nucleotides_NNS 2780_CD to_TO 2806_CD )_) ._SENT Reference_NN clones_NNS ._SENT |_SYM The_DT sensitivity_NN of_IN the_DT intHIV-2/SIV_NP primers_NNS was_VBD tested_VBN by_IN using_VBG known_VBN copy_NN numbers_NNS of_IN cloned_VBN material_NN representing_VBG HIV-1_NP ,_, HIV-2_NP ,_, and_CC SIVcpz_NP ._SENT For_IN HIV-2_NP ,_, a_DT cloned_VBN fragment_NN of_IN a_DT Centers_NPS for_IN Disease_NP Control_NP and_CC Prevention_NP HIV-2_NP isolate_NN (_( GB122_NP )_) was_VBD generated_VBN by_IN directly_RB cloning_VBG an_DT integrase_JJ PCR_NP fragment_NN into_IN the_DT pCR-TOPO_NN vector_NN in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS protocol_NN (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) ._SENT The_DT following_NN previously_RB described_VBD molecular_JJ clones_NNS were_VBD used_VBN for_IN SIVcpz_NP and_CC HIV-1_NP :_: 92UG037.1_NP (_( subtype_NN A_NP )_) ,_, 93TH233.3_NP (_( CRF01-AE_NP )_) ,_, 92RW009.6_JJ (_( subtype_NN A/C_NP )_) ,_, 92NG083.2_NP (_( CRF02-AG_NP )_) ,_, BCSG3_NP (_( subtype_NN B_NP )_) ,_, 93BR029.4_JJ (_( subtype_NN B/F_NP )_) ,_, 92BR026.8_JJ (_( subtype_NN C_NP )_) ,_, 94UG114.1_JJ (_( subtype_NN D_NP )_) ,_, 93_NP BR020.1_NP (_( subtype_NN F_NN )_) ,_, and_CC 90CR056.1_JJ (_( subtype_NN H_NN )_) ._SENT Known_VBN copy_NN numbers_NNS of_IN the_DT partial_JJ GB122_NP clone_NN ,_, the_DT infectious_JJ SIVcpz_NP clone_NN ,_, and_CC the_DT HIV-1_JJ molecular_JJ clones_NNS were_VBD used_VBN for_IN sensitivity_NN determination_NN ._SENT For_IN all_DT samples_NNS ,_, multiple_JJ dilutions_NNS were_VBD run_VBN in_IN duplicate_NN and_CC each_DT sample_NN was_VBD subjected_VBN to_TO PCR_NP amplification_NN at_IN least_JJS twice_RB ._SENT Viral_JJ isolates_NNS and_CC plasma_NN specimens_NNS ._SENT |_SYM HIV-1_NP ,_, HIV-2_NP ,_, and_CC SIV_NP isolates_NNS were_VBD generated_VBN by_IN previously_RB described_VBN cocultivation_NN procedures_NNS ._SENT DNA_NP or_CC RNA_NP or_CC both_DT from_IN cultured_JJ material_NN were_VBD used_VBN to_TO test_VB these_DT primers_NNS on_IN a_DT wide_JJ variety_NN of_IN primate_NN lentivirus_NN isolates_NNS ._SENT The_DT SIV_NP specimens_NNS included_VBD 7_CD SIVsm_NN (_( sooty_JJ mangabey_NN )_) specimens_NNS ,_, 1_CD SIVstm_NN (_( stumptail_NN macaque_NN )_) specimen_NN ,_, 1_CD SIVrcm_NN (_( red-capped_JJ mangabey_NN )_) specimen_NN ,_, 4_CD SIVagm_NN (_( African_JJ green_JJ monkey_NN )_) specimens_NNS ,_, 1_CD SIVmnd_NP (_( mandrill_NN )_) specimen_NN ,_, 1_CD SIVsyk_NP specimen_NN ,_, 1_CD SIVcpz_NP specimen_NN ,_, and_CC SIVhu_NP (_( an_DT isolate_NN derived_VBN from_IN a_DT human_NN accidentally_RB infected_VBN with_IN SIVB670_NP )_) ._SENT Additionally_RB ,_, 22_CD HIV-2_NP specimens_NNS ,_, including_VBG uncultured_JJ peripheral_JJ blood_NN lymphocytes_NNS from_IN 10_CD HIV-2-infected_JJ persons_NNS and_CC 12_CD previously_RB cultured_VBN isolates_NNS ,_, were_VBD included_VBN in_IN the_DT study_NN ._SENT A_DT plasma_NN panel_NN from_IN known_VBN HIV-1-seropositive_JJ individuals_NNS (_( Boston_NP Biomedical_NP Inc._NP ,_, Boston_NP ,_, Mass._NP )_) ,_, including_VBG 1_CD specimen_NN each_DT from_IN Argentina_NP ,_, Canada_NP ,_, China_NP ,_, and_CC Mozambique_NP ,_, 2_CD from_IN the_DT United_NP States_NPS ,_, 3_CD from_IN Thailand_NP ,_, 5_CD from_IN Zimbabawe_NP ,_, 6_CD each_DT from_IN Uganda_NP and_CC Ivory_NP Coast_NP ,_, and_CC 8_CD from_IN Ghana_NP ,_, and_CC an_DT HIV-2-seropositive_JJ panel_NN (_( Boston_NP Biomedical_NP Inc._NP )_) ,_, including_VBG 14_CD specimens_NNS from_IN Ivory_NP Coast_NP ,_, were_VBD also_RB used_VBN for_IN viral_JJ RNA_NP detection_NN by_IN RT-PCR_NP analysis_NN using_VBG the_DT intHIV-SIV_NN primers_NNS ._SENT PCR_NP ._SENT |_SYM DNA_NP preparation_NN was_VBD done_VBN by_IN proteinase_NN K_NN digestion_NN in_IN a_DT Tris-Triton_NP buffer_NN ,_, and_CC RNA_NP was_VBD extracted_VBN by_IN using_VBG the_DT QIAamp_NN viral_JJ RNA_NP kit_NN according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN (_( Qiagen_NP Inc._NP ,_, Valencia_NP ,_, Calif._NP )_) ._SENT Protocols_NNS for_IN RNA_NP extraction_NN and_CC conditions_NNS for_IN RT-PCR_NP and_CC PCR_NP are_VBP described_VBN elsewhere_RB ,_, except_IN that_WDT an_DT annealing_VBG temperature_NN of_IN 50C_NP was_VBD used_VBN for_IN both_CC the_DT primary_JJ and_CC secondary_JJ intHIV-2/SIV_NN primer_NN sets_NNS ._SENT All_DT reactions_NNS were_VBD carried_VBN out_RP with_IN appropriate_JJ negative_JJ controls_NNS to_TO detect_VB possible_JJ contamination_NN ._SENT Sequence_NN and_CC phylogenetic_JJ analysis_NN ._SENT |_SYM Selected_JJ nested-PCR_NN products_NNS were_VBD purified_VBN with_IN the_DT QIAquick_NP PCR_NP purification_NN kit_NN (_( Qiagen_NP )_) and_CC sequenced_JJ with_IN Big-dye_NP terminators_NNS (_( Perkin-Elmer_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) on_IN an_DT automated_JJ 377_CD DNA_NN sequencer_NN (_( Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT Sequences_NNS were_VBD aligned_VBN with_IN CLUSTAL_NP W_NP (_( version_NN 1.74_CD )_) after_IN editing_VBG ,_, and_CC phylogenetic_JJ trees_NNS were_VBD constructed_VBN by_IN the_DT neighbor-joining_JJ method_NN using_VBG the_DT PHYLIP_NN ,_, version_NN 3.5c_NN ,_, package_NN ._SENT Nucleotide_NN sequence_NN accession_NN numbers_NNS ._SENT |_SYM The_DT GenBank_NP accession_NN numbers_NNS for_IN the_DT sequences_NNS obtained_VBN in_IN this_DT study_NN are_VBP to_TO ._SENT Analysis_NN of_IN a_DT cloned_VBN fragment_NN from_IN HIV-2_NP (_( GB122_NP )_) revealed_VBD that_IN the_DT intHIV-2/SIV_NN primers_NNS reliably_RB amplified_VBN as_IN few_JJ as_IN 25_CD copies_NNS of_IN HIV-2_NP per_IN PCR_NP ._SENT Moreover_RB ,_, these_DT primers_NNS also_RB detected_VBD SIVcpz_NP with_IN the_DT same_JJ sensitivity_NN ._SENT We_PP next_RB examined_VBD the_DT cross-reactivity_NN of_IN these_DT primers_NNS with_IN HIV-1_NP ._SENT Amplifications_NNS were_VBD performed_VBN with_IN HIV-1_NP group_NN M_NP molecular_JJ clones_NNS with_IN inputs_NNS of_IN 100_CD ,_, 50_CD ,_, and_CC 25_CD copies_NNS per_IN PCR_NP ._SENT All_DT of_IN the_DT HIV-1_NP group_NN M_NN subtypes_NNS tested_VBN with_IN the_DT exception_NN of_IN subtypes_NNS C_NP and_CC D_NP were_VBD amplified_VBN at_IN 25_CD copies_NNS per_IN reaction_NN ;_: subtypes_NNS C_NP and_CC D_NP could_MD only_RB be_VB amplified_VBN at_IN 100_CD copies_NNS per_IN reaction_NN ._SENT Thus_RB ,_, HIV-2_NP ,_, SIVcpz_NP ,_, and_CC all_DT HIV-1_JJ subtype_NN molecular_JJ clones_NNS were_VBD consistently_RB amplified_VBN at_IN 100_CD copies_NNS per_IN reaction_NN ._SENT In_IN addition_NN ,_, RNA_NP from_IN the_DT culture_NN supernatant_JJ of_IN an_DT HIV-1_NP group_NN N_NP virus_NN was_VBD amplified_VBN ._SENT We_PP next_RB tested_VBD the_DT amplification_NN efficiency_NN of_IN the_DT primers_NNS for_IN 12_CD HIV-2_JJ primary_JJ isolates_NNS ._SENT The_DT intHIV-2/SIV_NP primers_NNS amplified_VBD all_DT samples_NNS ,_, which_WDT included_VBD nine_CD HIV-2_NP subtype_NN A_DT specimens_NNS ,_, two_CD subtype_NN B_NN specimens_NNS ,_, and_CC one_CD subtype_NN A/B_NP recombinant_JJ specimen_NN ._SENT As_IN cultured_JJ isolates_NNS from_IN most_JJS of_IN the_DT specimens_NNS were_VBD not_RB available_JJ ,_, we_PP performed_VBD PCR_NP amplification_NN on_IN DNA_NN derived_VBN from_IN uncultured_JJ peripheral_JJ blood_NN mononuclear_JJ cells_NNS (_( PBMC_NP )_) ._SENT Analysis_NN of_IN primary_JJ PBMC_NN from_IN 10_CD HIV-2-infected_JJ individuals_NNS revealed_VBD that_DT DNA_NN of_IN those_DT from_IN 8_CD was_VBD amplified_VBN by_IN using_VBG these_DT primers_NNS ,_, giving_VBG an_DT amplification_NN efficiency_NN of_IN 80_CD %_NN ._SENT These_DT results_NNS are_VBP comparable_JJ to_TO those_DT for_IN the_DT primers_NNS identified_VBN in_IN the_DT protease_NN region_NN ,_, which_WDT are_VBP highly_RB specific_JJ for_IN HIV-2_NP detection_NN only_RB ._SENT The_DT high_JJ sensitivity_NN of_IN HIV-2_NP DNA_NP detection_NN from_IN primary_JJ PBMC_NP led_VBD us_PP to_TO test_VB the_DT amplification_NN efficiency_NN of_IN intHIV-2/SIV_NN for_IN detection_NN of_IN plasma_NN viremia_NN from_IN HIV-2-_NP and_CC HIV-1-infected_NP individuals_NNS ._SENT Results_NNS from_IN duplicate_JJ experiments_NNS showed_VBD that_IN the_DT intHIV-2/SIV_NP primers_NNS were_VBD able_JJ to_TO amplify_VB from_IN RNA_NP 5_CD of_IN the_DT 14_CD HIV-2_NP plasma_NN samples_NNS tested_VBN (_( 35.7_CD %_NN )_) ._SENT Amplification_NN with_IN RNA_NP from_IN the_DT same_JJ samples_NNS with_IN protease_NN primers_NNS ,_, previously_RB shown_VBN to_TO amplify_VB as_RB few_JJ as_IN 10_CD cDNA_NN copies_NNS from_IN PBMC_NP ,_, resulted_VBN in_IN only_RB 43_CD %_NN amplification_NN efficiency_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Further_RBR ,_, amplification_NN of_IN RNA_NP from_IN 34_CD HIV-1_JJ plasma_NN samples_NNS by_IN using_VBG intHIV-2/SIV_NN primers_NNS resulted_VBN in_IN amplification_NN of_IN RNA_NP from_IN 19_CD (_( 56_CD %_NN )_) samples_NNS ._SENT In_IN comparison_NN intM-Z_NN primers_NNS ,_, previously_RB shown_VBN to_TO amplify_VB HIV-1_NP and_CC SIVcpz_NP efficiently_RB ,_, amplified_VBD RNA_NP from_IN all_DT specimens_NNS (_( 100_CD %_NN )_) ._SENT Previous_JJ studies_NNS have_VBP developed_VBN HIV-2-specific_JJ primers_NNS that_WDT allow_VBP detection_NN of_IN HIV-2_NP from_IN DNA_NP in_IN persons_NNS dually_RB infected_VBN with_IN HIV-1_NP and_CC HIV-2_NP ._SENT More_RBR recently_RB ,_, qualitative_JJ and_CC quantitative_JJ PCR-based_JJ assays_NNS for_IN specific_JJ detection_NN of_IN HIV-2_NP have_VBP been_VBN developed_VBN ._SENT The_DT intHIV-2/SIV_NP primers_NNS described_VBD here_RB were_VBD designed_VBN to_TO be_VB as_RB cross-reactive_JJ as_IN possible_JJ ,_, so_RB that_IN any_DT new_JJ variants_NNS of_IN HIV-2_NP or_CC HIV-1_NP or_CC cross-species_NNS transmission_NN of_IN SIVs_NP from_IN nonhuman_NN primates_NNS to_TO humans_NNS could_MD be_VB detected_VBN ._SENT The_DT intHIV-2/SIV_NP primers_NNS detected_VBD 80_CD %_NN (_( 10_CD of_IN 12_CD )_) of_IN the_DT PBMC_NN from_IN HIV-2-infected_JJ persons_NNS but_CC detected_VBN viremia_NN in_IN only_RB 36_CD %_NN (_( 5_CD of_IN 14_CD )_) of_IN plasma_NN samples_NNS ._SENT While_IN the_DT sensitivity_NN of_IN amplification_NN from_IN primary_JJ DNA_NN was_VBD good_JJ ,_, one_CD of_IN the_DT limitations_NNS of_IN the_DT intHIV-2/SIV_NP primers_NNS is_VBZ that_IN they_PP are_VBP not_RB sensitive_JJ for_IN detection_NN of_IN HIV-2_NP plasma_NN viremia_NN ._SENT However_RB ,_, using_VBG previously_RB characterized_VBN HIV-2_NP protease_NN primers_NNS resulted_VBN in_IN comparable_JJ efficiency_NN of_IN amplification_NN of_IN HIV-2_NP from_IN viral_JJ RNA_NP ._SENT The_DT lower_JJR sensitivity_NN of_IN HIV-2_JJ detection_NN from_IN plasma_NN may_MD be_VB due_JJ to_TO low_JJ copy_NN numbers_NNS of_IN HIV-2_NP ,_, and_CC indeed_RB several_JJ studies_NNS have_VBP established_VBN that_IN HIV-2-infected_JJ persons_NNS have_VBP significantly_RB lower_JJR viremia_NN than_IN those_DT infected_JJ with_IN HIV-1_NP ._SENT Because_IN of_IN the_DT highly_RB conserved_VBN nature_NN of_IN the_DT integrase_NN gene_NN between_IN HIV-2_NP and_CC SIVs_NP ,_, it_PP was_VBD predicted_VBN that_IN the_DT intHIV-2/SIV_NN primers_NNS could_MD amplify_VB SIVs_NP from_IN diverse_JJ primate_NN species_NNS ._SENT We_PP next_RB verified_VBD this_DT hypothesis_NN by_IN using_VBG viral_JJ DNA_NP or_CC RNA_NP from_IN culture_NN material_NN of_IN diverse_JJ SIVs_NNS from_IN sooty_JJ mangabeys_NNS (_( SIVsmm3_NP ,_, -9_CD ,_, -21_CD ,_, -54_CD ,_, -55_CD ,_, -74_CD ,_, and_CC -156_CD )_) ,_, red-capped_JJ mangabeys_NNS (_( SIVrcm_NP )_) ,_, stumptail_NN macaques_NNS (_( SIVstm_NP )_) ,_, mandrills_NNS (_( SIVmndBK-12_NP )_) ,_, Sykes_NP monkeys_NNS (_( SIVsyk_NP )_) ,_, and_CC African_JJ green_JJ monkeys_NNS (_( AgmKenya_NP ,_, AgmTYO1_NP ,_, AgmTAN1_NP ,_, and_CC Agm1584_NP )_) ._SENT In_IN addition_NN ,_, the_DT primers_NNS amplified_VBD an_DT SIVhu_NP and_CC SIV_NP from_IN chimpanzees_NNS (_( SIVcpz_NP )_) ,_, the_DT species_NN that_WDT has_VBZ been_VBN shown_VBN to_TO be_VB the_DT natural_JJ reservoir_NN for_IN HIV-1_NP ._SENT These_DT data_NNS suggest_VBP that_IN intHIV-2/SIV_NP primers_NNS are_VBP sensitive_JJ for_IN detecting_VBG DNA_NP and_CC RNA_NP from_IN HIV-2_NP ,_, as_RB well_RB as_IN diverse_JJ lineages_NNS of_IN SIVs_NP ._SENT Since_IN the_DT primers_NNS had_VBD broad_JJ specificity_NN for_IN detection_NN of_IN HIV-2_NP ,_, HIV-1_NP ,_, and_CC SIVs_NP ,_, we_PP next_RB examined_VBD if_IN phylogenetic_JJ analysis_NN of_IN amplified_VBN sequences_NNS would_MD permit_VB distinction_NN of_IN HIV-2_NP ,_, HIV-1_NP ,_, and_CC SIV_NP lineages_NNS ._SENT The_DT products_NNS amplified_VBN by_IN using_VBG intHIV-2/SIV_NN from_IN cultured_JJ isolates_NNS of_IN HIV-2_NP and_CC SIVs_NP ,_, plasma_NN of_IN HIV-2-infected_JJ persons_NNS ,_, and_CC selected_VBD HIV-1s_NP were_VBD sequenced_JJ ,_, and_CC a_DT 420-bp_JJ segment_NN was_VBD used_VBN for_IN phylogenetic_JJ analysis_NN ._SENT Figure_NN depicts_VBZ the_DT relationship_NN of_IN HIV-2_NP and_CC SIV_NP sequences_NNS derived_VBN from_IN the_DT amplified_VBN integrase_NN products_NNS ._SENT The_DT overall_JJ topology_NN of_IN the_DT tree_NN remains_VBZ the_DT same_JJ as_IN those_DT previously_RB demonstrated_VBN for_IN full-length_JJ integrase_NN sequences_NNS ._SENT HIV-2_JJ and_CC several_JJ SIVs_NNS amplified_VBN and_CC sequenced_VBN from_IN this_DT study_NN revealed_VBD distinct_JJ cluster_NN patterns_NNS similar_JJ to_TO those_DT of_IN the_DT previously_RB characterized_VBN reference_NN clusters_NNS ._SENT As_IN expected_VBN ,_, HIV-2_NP and_CC SIV_NP from_IN sooty_JJ mangabeys_NNS formed_VBD a_DT monophyletic_JJ cluster_NN ._SENT Sequences_NNS from_IN SIVrcm_NP ,_, SIVmnd_NP ,_, SIVagm_NP ,_, and_CC SIVcpz_NP were_VBD highly_RB divergent_JJ and_CC represented_VBN distinct_JJ lineages_NNS ._SENT Similar_JJ phylogenetic_JJ analysis_NN of_IN sequences_NNS amplified_VBN from_IN persons_NNS infected_VBN with_IN HIV-1_JJ group_NN M_NN or_CC group_NN O_NN revealed_VBD clustering_VBG with_IN their_PP$ respective_JJ group_NN M_NN or_CC group_NN O_NN sequences_NNS ,_, although_IN the_DT subtype_NN designation_NN within_IN the_DT group_NN M_NN sequences_NNS was_VBD not_RB reliable_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, despite_IN the_DT small_JJ fragment_NN size_NN ,_, the_DT phylogenetic_JJ analysis_NN of_IN this_DT region_NN provides_VBZ an_DT adequate_JJ clustering_VBG pattern_NN to_TO identify_VB the_DT correct_JJ lineages_NNS of_IN SIVs_NP ,_, as_RB well_RB as_IN the_DT HIV_NP type_NN and_CC group_NN ._SENT The_DT intHIV-2/SIV_NP primers_NNS were_VBD able_JJ to_TO amplify_VB specimens_NNS from_IN five_CD major_JJ lineages_NNS of_IN primate_NN lentiviruses_NNS ._SENT Additionally_RB ,_, HIV-1_NP and_CC HIV-2_NP sequences_NNS were_VBD correctly_RB identified_VBN ._SENT However_RB ,_, the_DT integrase_NN region_NN was_VBD not_RB sufficient_JJ to_TO provide_VB clade_JJ designation_NN for_IN either_DT HIV-1_NP or_CC HIV-2_NP ._SENT In_IN summary_NN ,_, the_DT primers_NNS described_VBD here_RB provide_VB a_DT quick_JJ method_NN to_TO amplify_VB primate_NN lentivirus_NN genomic_JJ sequences_NNS from_IN diverse_JJ species_NNS of_IN primates_NNS ,_, as_RB well_RB as_IN PBMC_NP from_IN HIV-1-_NP and_CC HIV-2-infected_NP persons_NNS ._SENT This_DT assay_NN should_MD provide_VB a_DT useful_JJ tool_NN for_IN recognizing_VBG a_DT wide_JJ range_NN of_IN lentivirus_NN infections_NNS from_IN nonhuman_NN primates_NNS and_CC humans_NNS ,_, both_CC for_IN identification_NN of_IN HIV_NP variants_NNS worldwide_RB and_CC for_IN early_JJ detection_NN of_IN potential_JJ cross-species_NNS transmission_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Detection_NP of_IN HIV-2_NP ,_, SIVcpz_NP ,_, and_CC diverse_JJ HIV-1_JJ molecular_JJ clones_NNS by_IN using_VBG intHIV-2/SIV_NN primers_NNS ._SENT Detection_NN of_IN HIV-2_NP ,_, SIVcpz_NP ,_, and_CC diverse_JJ HIV-1_JJ molecular_JJ clones_NNS by_IN using_VBG intHIV-2/SIV_NN primers_NNS ._SENT Known_VBN copy_NN numbers_NNS (_( 100_CD ,_, 50_CD ,_, and_CC 25_CD copies_NNS per_IN PCR_NP )_) of_IN reference_NN clones_NNS of_IN HIV-2_NP (_( GB122_NP )_) ,_, SIVcpz_NP ,_, and_CC HIV-1_JJ subtypes_NNS A_DT (_( 92UG037_JJ )_) ,_, B_NP (_( BCSG3_NP )_) ,_, C_NP (_( 92BR026_NN )_) ,_, D_NP (_( 94UG114_NN )_) ,_, F_NP (_( 93BR020_NN )_) ,_, H_NP (_( 90CR056_NN )_) ,_, AC_NP (_( 92RW009_NN )_) ,_, CRF01-AE_NP (_( 93TH233_NN )_) ,_, CRF02-AG_NP (_( 92NG083_NN )_) ,_, and_CC B/F_NP (_( 93BR029_NN )_) were_VBD amplified_VBN by_IN using_VBG intHIV-2/SIV_NN primers_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM Phylogenetic_JJ positions_NNS of_IN HIV-2_JJ sequences_NNS from_IN this_DT study_NN (_( boldface_JJ and_CC underlined_VBN )_) and_CC reference_NN HIV-2_NP and_CC SIV_NP sequences_NNS in_IN the_DT integrase_NN region_NN ._SENT Phylogenetic_JJ positions_NNS of_IN HIV-2_JJ sequences_NNS from_IN this_DT study_NN (_( boldface_JJ and_CC underlined_VBN )_) and_CC reference_NN HIV-2_NP and_CC SIV_NP sequences_NNS in_IN the_DT integrase_NN region_NN ._SENT Trees_NNS were_VBD derived_VBN from_IN nucleotide_NN sequence_NN alignment_NN of_IN 413_CD bp_NN by_IN using_VBG the_DT neighbor-joining_NN method_NN ._SENT Numbers_NNS at_IN the_DT nodes_NNS represent_VBP the_DT percentages_NNS of_IN bootstrap_NN values_NNS (_( only_JJ values_NNS >70_NN are_VBP shown_VBN )_) ._SENT FIG._NN 3_CD ._SENT |_SYM Phylogenetic_JJ position_NN of_IN HIV-1_JJ sequences_NNS from_IN this_DT study_NN (_( boldface_JJ and_CC underlined_VBN )_) and_CC previously_RB reported_VBD HIV-1_NP and_CC SIVcpz_NP strains_NNS in_IN integrase_NN regions_NNS ._SENT Phylogenetic_JJ position_NN of_IN HIV-1_JJ sequences_NNS from_IN this_DT study_NN (_( boldface_JJ and_CC underlined_VBN )_) and_CC previously_RB reported_VBD HIV-1_NP and_CC SIVcpz_NP strains_NNS in_IN integrase_NN regions_NNS ._SENT The_DT topology_NN shows_VBZ an_DT overall_JJ branching_NN order_NN consistent_JJ with_IN previously_RB reported_VBN phylogenies_NNS for_IN full-length_JJ sequences_NNS ._SENT Trees_NNS were_VBD derived_VBN from_IN nucleotide_NN sequence_NN alignments_NNS (_( consensus_NN lengths_NNS of_IN 412_CD bp_NN )_) using_VBG the_DT neighbor-joining_NN method_NN ._SENT Horizontal_JJ branch_NN lengths_NNS are_VBP drawn_VBN to_TO scale_VB ,_, with_IN the_DT bar_NN indicating_VBG 0.10_CD nucleotide_NN substitution_NN per_IN site_NN ._SENT Numbers_NNS at_IN the_DT nodes_NNS indicate_VBP the_DT percentages_NNS of_IN bootstrap_NN values_NNS (_( out_RB of_IN 500_CD )_) in_IN which_WDT the_DT cluster_NN to_TO the_DT right_NN is_VBZ supported_VBN (_( only_RB values_VBZ 70_CD %_NN or_CC above_RB are_VBP shown_VBN )_) ._SENT TABLE_NN 1_CD |_SYM Amplification_NP of_IN HIV-2_NP and_CC HIV-1_NP isolates_VBZ with_IN intHIV-2/SIV_NN primers_NNS TABLE_NP 2_CD |_SYM Comparative_JJ sensitivities_NNS of_IN intHIV-2/SIV_NN and_CC intM-Z_NN primers_NNS for_IN PBMC_NP DNA_NP and_CC plasma_NN RNA_NP detection_NN TABLE_NP 3_CD |_SYM Detection_NN of_IN diverse_JJ SIV_NP isolates_NNS with_IN intHIV-2/SIV_NN primers_NNS 